Evidence map›Paper›PMID 21712999›Full record

ArticlePloS one2011

Reconstruction of endometrium from human endometrial side population cell lines.

Irene Cervelló, Aymara Mas, Claudia Gil-Sanchis, Laura Peris, Amparo Faus, Philippa T K Saunders, Hilary O D Critchley, Carlos Simón

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02144987 (New Therapeutic Approaches to Treat Asherman's Syndrome and Endometrial Atrophy Based in BM Stem Cells Autologous Transplantation), which is not on this map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02144987 phase4completednot on this mapstarted 2013, after this paper: background citation

New Therapeutic Approaches to Treat Asherman's Syndrome and Endometrial Atrophy Based in BM Stem Cells Autologous Transplantation

TypeinterventionalSponsorInstituto Valenciano de Infertilidad, IVI VALENCIARan2013 to 2014Enrolled16ConditionsAsherman's Syndrome, Endometrium, Atrophy, CervixArmsBone Marrow CD133+ Stem Cell Transplantation
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Pathogenesis of Endometriosis and Endometriosis-Associated Cancers.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Mechanisms of Regeneration and Fibrosis in the Endometrium.Annual review of cell and developmental biology · 2023
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. The Main Theories on the Pathogenesis of Endometriosis.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Modeling Endometrium Biology and Disease.Journal of personalized medicine · 2022
    Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Irene CervellóFundación IVI-Instituto Universitario IVI, Universidad de Valencia, INCLIVA, Valencia, Spain.
Aymara Mas
Claudia Gil-Sanchis
Laura Peris
Amparo Faus
Philippa T K Saunders
Hilary O D Critchley
Carlos Simón
Valencian Infertility Institute · ESUniversitat de València · ESCentro de Investigacion Principe Felipe · ESMRC Centre for Reproductive Health · GBUniversity of Edinburgh · GB

Funding

Medical Research Council G0600048Medical Research Council G0600048(80179)Medical Research Council G1002033Medical Research Council G1100356Medical Research Council MC_U127685844Medical Research Council U1276.00.002.00005.01Medical Research Council U.1276.00.002.00005.01 (85844)
6 · The paper itself

Abstract

Endometrial regeneration is mediated, at least in part, by the existence of a specialized somatic stem cell (SSC) population recently identified by several groups using the side population (SP) technique. We previously demonstrated that endometrial SP displays genotypic, phenotypic and the functional capability to develop human endometrium after subcutaneous injection in NOD-SCID mice. We have now established seven human endometrial SP (hESP) cell lines (ICE 1-7): four from the epithelial and three from the stromal fraction, respectively. SP cell lines were generated under hypoxic conditions based on their cloning efficiency ability, cultured for 12-15 passages (20 weeks) and cryopreserved. Cell lines displayed normal 46XX karyotype, intermediate telomerase activity pattern and expressed mRNAs encoding proteins that are considered characteristic of undifferentiated cells (Oct-4, GDF3, DNMT3B, Nanog, GABR3) and those of mesodermal origin (WT1, Cardiac Actin, Enolase, Globin, REN). Phenotype analysis corroborated their epithelial (CD9+) or stromal (vimentin+) cell origin and mesenchymal (CD90+, CD73+ and CD45⁻) attributes. Markers considered characteristic of ectoderm or endoderm were not detected. Cells did not express either estrogen receptor alpha (ERα) or progesterone receptor (PR). The hESP cell lines were able to differentiate in vitro into adipocytes and osteocytes, which confirmed their mesenchymal origin. Finally, we demonstrated their ability to generate human endometrium when transplanted beneath the renal capsule of NOD-SCID mice. These findings confirm that SP cells exhibit key features of human endometrial SSC and open up new possibilities for the understanding of gynecological disorders such as endometriosis or Asherman syndrome. Our cell lines can be a valuable model to investigate new targets for endometrium proliferation in endometriosis.

Indexed as

AnimalsBiomarkersCell DifferentiationCell LineCell SeparationEndometriumEpithelial CellsEstrogen Receptor alphaFemaleHumansKaryotypingMiceMice, Inbred NODMice, SCIDPhenotypeReceptors, ProgesteroneBiomarkersEstrogen Receptor alphaReceptors, Progesterone

Identifiers

PMID21712999
PMCPMC3119688
OpenAlexW2064441872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.